Bizarre Patents
Decorative Jeweled Wheel Cover
An improved wheel is provided wherein decorative items such as gem stones are embedded in either the wheel surface, a special mounting section attached to the wheel surface, or to a spoke strap that wraps around each spoke and positions embedded gem stones on the outside surface of the spoke.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20060014805 | Pesticidal fluoroalkene derivatives Pesticidal fluoroalkene derivatives (I) wherein A is oxygen, NRa; Ra is hydrogen; optionally halogenated alkyl, alkenyl, alkynyl; X is hydrogen, halogen; optionally halogenated alkyl or phenyl; R1,R2 are hydrogen, halogen, hyd... | 01/19/2006 |
| 20050261328 | Pharmaceutical composition comprising beta-3-adrenoceptor-agonists and antimuscarinic agents A pharmaceutical composition useful in the treatment of functional bladder disorders comprising an antimuscarinic agent and a beta-3-adrenoceptor agonist is described. ... | 11/24/2005 |
| 20050256169 | Nitric oxide scavengers Therapeutic compositions capable of removing excess nitric oxide are provided. The therapeutic compositions include nitronyl nitroxide monoradicals, B12 derivatives, flavonoid derivatives, the like and combinations thereof. The therapeutic compositions can be utilized i... | 11/17/2005 |
| 20050256167 | Preparation and use of imidazole derivatives for treatment of obesity This invention relates to substituted imidazole derivatives which have been found to suppress appetite and induce weight loss. The invention also provides methods for synthesis of the compounds, pharmaceutical compositions comprising the compounds, and methods of using ... | 11/17/2005 |
| 20050238729 | Inhibition of biogenic sulfide production via biocide and metabolic inhibitor combination Biogenic sulfide production is synergistically inhibited by treating sulfate-reducing bacteria (SRB) with a biocide and a metabolic inhibitor. The biocide directly kills a first portion of the SRB. The metabolic inhibitor inhibits sulfate-reducing growth of a second por... | 10/27/2005 |
| 20050239856 | Method for prophylaxis and treatment of diabetic complications with 4{alpha-hydroxy-2-methyl-5-(1-imidazolyl)benzyl}-3,5-dimethylbenzoic acid and derivatives The present invention relates to an agent for the prophylaxis and treatment of diabetic complications comprising, as an active ingredient, 4-[α-hydroxy-2-methyl-5(1-imidazolyl)benzyl]-3,5-dimethylbenzoic acid, an optically active compound thereof or a pharmaceutically ... | 10/27/2005 |
| 20050234106 | Cycloalkyl inhibitors of potassium channel function Novel cycloalkyl compounds useful as inhibitors of potassium channel function (especially inhibitors of the Kv1 subfamily of voltage gated K+ channels, especially inhibitors Kv1.5 which has been linked to the ultra-rapidly activating del... | 10/20/2005 |
| 20050227978 | Fibrosis inhibitor Medicament being useful as a fibrosis inhibitor for organs or tissues, which comprises a compound of the formula (I): wherein Ring Z is optionally substituted pyrrole ring, etc.; W2 is —CO—, —SO2—, optionally substituted C1 10/13/2005 | |
| 20050222136 | Active substance combination The present invention relates to an active substance combination including at least one substituted carbinol compound and at least one non-steroidal anti-inflammatory drug (NSAID), a medicament including the active substance combination, a pharmaceutical formulation inc... | 10/06/2005 |
| 20050222135 | Active substance combination The present invention relates to an active substance combination comprising at least one substituted carbinol compound and at least one opioid, a medicament comprising said active substance combination, a pharmaceutical formulation comprising said active substance combi... | 10/06/2005 |
| 20050209275 | Beta 2-adrenergic receptor agonists Disclosed are multibinding compounds which are β2-adrenergic receptor agonists and are useful in the treatment and prevention of respiratory diseases such as asthma, bronchitis. They are also useful in the treatment of nervous system injury and premature labor. ... | 09/22/2005 |
| 20050203064 | Novel oxidized thioether derivatives The present invention provides the compounds of formula I their pharmaceutically acceptable salts or esters, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, pharmaceutical compositions containing them and their m... | 09/15/2005 |
| 20050203111 | Compositions and methods for preventing and treating skin and hair conditions The present invention discloses compositions and methods for the prevention and treatment of skin and hair diseases, such as, for example, alopecia, psoriasis, and keloids. In one embodiment, the present invention discloses a method for preventing and treating hair loss... | 09/15/2005 |
| 20050197377 | CCK-1 receptor modulators Certain imidazole compounds are CCK1 modulators useful in the treatment of CCK1 mediated diseases. ... | 09/08/2005 |
| 20050186195 | Use of creatine or creatine compounds for skin preservation The present invention relates to the use of creatine compounds such as, for example, creatine, creatine phosphate or analogs of creatine, such as creatine-pyruvate, creatine-ascorbate, cyclocreatine, 3 guanidinopropionic acid, guanidinoacetate, homocyclocreatine, guanid... | 08/25/2005 |
| 20050187276 | Compounds, compositions and methods The present invention provides methods and pharmaceutical compositions for inhibiting expressions of HIF and HIF regulated genes, inhibiting angiogenesis, inducing cell cycle arrest in tumor cells, and treating cell proliferating diseases or conditions. ... | 08/25/2005 |
| 20050186194 | Use of creatine or creatine compounds for skin preservation The present invention relates to the use of creatine compounds such as, for example, creatine, creatine phosphate or analogs of creatine, such as creatine-pyruvate, creatine-ascorbate, cyclocreatine, 3 guanidinopropionic acid, guanidinoacetate, homocyclocreatine, guanid... | 08/25/2005 |
| 20050171163 | MCP-1 receptor antagonists and methods of use thereof The present invention relates to sulfones that are useful in the treatment of chemokine-mediated disorders. In certain embodiments, the present invention concerns the compounds that are MCP-1 receptor antagonists. ... | 08/04/2005 |
| 20050171176 | Pharmaceutically active aromatic guanylhydrazones The present invention relates to aromatic guanylhydrazone compounds and their use as pharmaceutically active agents, especially for prophylaxis and treatment of virally caused diseases and infections, including opportunistic infections. The inventive guanylhydrazone com... | 08/04/2005 |
| 20050171069 | Methods and reagents for the treatment of multiple sclerosis The invention features methods and reagents for the diagnosis, monitoring, and treatment of multiple sclerosis. The invention is based in part on the discovery that Chlamydia is present in patients with multiple sclerosis, and that anti-chlamydial agents improve or sust... | 08/04/2005 |
| 20050159470 | Histone deacetylase inhibitors Histone deacetylase inhibitors and uses thereof are provided that have the general Z-Q-L-M
| |
| 20050148547 | Fungicidal mixtures based on benzamidoxime derivatives and azoles Fungicidal mixtures, comprising as active components (1) a benzamidoxime derivative of the formula I where the substituent and the index may have the following meanings:
| |
| 20050142628 | Use The present invention relates to the use of NAD(P)H oxidase inhibitors to increase cellular uptake of glucose and in the treatment and/or prevention of diseases caused by insulin resistance or diseases related thereto, such as type II diabetes. Specifically, the inventi... | 06/30/2005 |
| 20050137173 | Bicyclic cannabinoid agonists for the cannabinoid receptor Novel polycyclic cannabinoid analogs are presented which have preferentially high affinities for the cannabinoid CB2 receptor sites. The improved receptor affinity makes these analogs therapeutically useful as medications in individuals and animals for treatment of pain... | 06/23/2005 |
| 20050131043 | Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles This invention relates to a compound and the use of the compound of the formula wherein R1, R2, R3, R4 and R5 are as defined in the description, A signifies —CH═CH— or —C≡C—; and B signifies ... | 06/16/2005 |
| 20050124632 | Remedies and/or preventives for diabetic ischemic heart diseases An agent for therapeutic and/or prophylactic treatment of heart failure or arrhythmia in diabetic ischemic heart disease, which comprises as an active ingredient an aminobenzenesulfonic acid derivative represented by the following general formula (I): (wherein... | 06/09/2005 |
| 20050107383 | 3-ARYLPHENYL SULFIDE DERIVATIVE AND INSECTICIDE AND MITICIDE 3-Arylphenyl sulfide derivatives represented by general formula (I): (wherein R is a C2-C6 alkyl group, a C2-C6 alkenyl group, a C2-C6 alkynyl group or the like, B0 to B2 a... | 05/19/2005 |
| 20050107449 | Peroxisome proliferator activated receptor modulators The present invention is directed to compounds represented by the following structural formula, and pharmaceutically acceptable salts thereof, Formula I. (Formula I); wherein: (a) R5 is selected from the group consisting of (C1-C6) alkyl, (C1<... | 05/19/2005 |
| 20050107442 | Compounds that modulate PPAR activity and methods of preparation This invention discloses compounds that alter PPAR activity. The invention also discloses pharmaceutically acceptable salts of the compounds, pharmaceutically acceptable compositions comprising the compounds or their salts, and methods of using them as therapeutic agent... | 05/19/2005 |
| 20050101585 | Use of selective CB1-antagonists in medical treatments The use of selective CB1 receptor antagonistic compounds for treating and/or inhibiting CB1 receptor related diseases in juvenile patients (pediatric treatment), e.g. in particular obesity in juvenile patients, and/or for the treatment and/or inhib... | 05/12/2005 |
| 20050085523 | Imidazolyl and pyrazolyl ethyne compounds In accordance with the present invention, there is provided a novel class of heterocyclic compounds. Compounds of the invention contain a substituted, unsaturated five, six or seven membered heterocyclic ring that includes at least one nitrogen atom and at least one car... | 04/21/2005 |
| 20050085521 | Optically active azole derivative and process for producing the same A method for producing an optically active 2-phenyl-2,3,-dihydroxypropyl azole derivative, which is a useful compound in various fields. An optically active α-hydroxycarboxylic acid derivative represented by general formula (1) is used as a starting material and is al... | 04/21/2005 |
| 20050080122 | Anti-viral compounds The present invention relates generally to compounds useful in the amelioration of symptoms associated with viral infection. More particularly, the present invention relates to the use of compounds which exhibit a physiological effect on membranous and/or transmembranou... | 04/14/2005 |
| 20050075359 | Large conductance calcium-activated K channel opener There is disclosed a large conductance calcium-activated K channel opener comprising a compound of the formula (I): wherein R1 is aminosulfonyl, alkylsulfonyl, etc., R2 is hydrogen or halogen, R3 and R4 are hydrogen,... | 04/07/2005 |
| 20050075378 | Modulators of peroxisome proliferator activated receptors (ppar) The present invention is directed to a compound of formula I, and pharmaceutically acceptable salts, solvates, hydrates or stereoisomer thereof, which are useful in treating Syndrome X, Type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertensio... | 04/07/2005 |
| 20050075376 | Cycloalkyl heterocycles for treating Hepatitis C virus Compounds of Formula I are disclosed which inhibit hepatitis C NS5B RNA-dependent RNA polymerase and are useful for treating hepatitis C. Compositions and methods of using these compounds are also disclosed. ... | 04/07/2005 |
| 20050075375 | Heterocyclic compounds for treating hepatitis C virus The invention is directed to heterocyclic compounds and pharmaceutical compositions of the same for treating Hepatitis C virus. ... | 04/07/2005 |
| 20050070538 | Compounds and uses thereof in modulating amyloid beta Novel compounds, compositions, and kits are provided. Methods of modulating Aβ levels, and methods of treating a disease associated with aberrant Aβ levels are also provided. ... | 03/31/2005 |
| 20050054706 | Pharmaceutically active compounds and methods of use The invention provides substituted pyrazolidinone compounds, and methods of treatment and pharmaceutical compositions that utilize or comprise one or more such compounds. Compounds of the invention are useful for a variety of therapies, including treating or preventing ... | 03/10/2005 |
| 20050054618 | Use of glycogen phosphorylase inhibitors for treatment of cardiovascular diseases The present invention provides methods of treatment and prevention of early cardiac and early cardiovascular diseases, for instance of ischemic origin, such as left ventricular hypertrophy, coronary artery disease, essential hypertension, acute hypertensive emergency, c... | 03/10/2005 |
